Consortium Application  Logo
  • Section 1: Company Information

  •  -
  • Designated Employer Representative
  •  -
  • Section 2:

  • 📢 IMPORTANT ENROLLMENT NOTICE 📢

    All DOT employees must provide proof of a negative drug screen or previous Consortium enrollment prior to enrolling in the On The Dot Screenings Consortium Program. To use previous drug screen results, the test must have been taken within 30 days prior to joining.

     

     

  • Section 3:

    Driver Roster (For multi-driver fleets)
  • Browse Files
    Cancelof
  • Section 4:

    Membership Coverages & Services
  • Enrollment in the FMCSA Drug & Alcohol Testing Consortium includes the following:

    • Enrollment in a DOT-compliant random testing pool
    • DOT regulated system and testing procedures
    • Required pre-employment drug testing (unless exempt)
    • Random drug & alcohol testing (FMCSA percentages)
    • Medical Review Officer (MRO) review and result processing services
    • Post-accident, reasonable suspicion, return-to-duty, and follow-up testing coordination with our consortium
    • Management of positive or refusal-to-test results
    • Compliance records retention (per 49 CFR §382.401)
    • Annual MIS reporting support
    • Clearinghouse management, and reporting (violations & queries)
    • Immediate results release and electronic reporting upon receipt
    • DOT compliance certificate
    • Access to over 20,000 collection sites
  • Section 5:

    Responsibilites of the Member
  • SECTION 5: RESPONSIBILITIES OF THE MEMBER

    The Member agrees to:

    1. Abide by 49 CFR Part 40 and Part 382 of FMCSA regulations.
    2. Ensure no driver performs safety-sensitive functions without a negative pre-employment test result.
    3. Remove any driver from duty who tests positive or refuses to test.
    4. Notify the Consortium within 72 hours of new hires or terminations.
    5. Maintain a current DER who is accessible and responsive.
    6. Cooperate fully with all audits and record requests.
    7. Register and use the FMCSA Clearinghouse and authorize the Consortium to report violations on its behalf.
    8. Facilitate return-to-duty and follow-up testing as required under Subpart O.
       


     

  • Section 6:

    Fee's and Billing
  •  

    Description Owner - Operator Fleets
    Annual Consortium Fee* $0 Per year $0 Per Year
    Pre- Employment Drug Test $65 Per Test $65 Per Test
    Post- Accident/Reasonable Suspicion $70 Per Event

    $70 Per Event

    Return to Duty/Follow Up Management $75 Per Case $75 Per Case
    Each DOT Breath Alcohol Test $45 Per Test $45 Per Test
    Each DOT Urine Drug Test $60 Per Test $60 Per Test

     

    Testing Fee Includes: 5 Panel DOT Drug Screen, Collection of Specimen, Lab Testing with Confirmation, MRO Reporting, MIS Reports when required and/or requested, and Certified Random Selections – All DOT Approved.


    Reinstatement Fee $75 DOT Drug test is required for reinstatement

    FMCSA Clearinghouse registration fee (if OTD performs) $25 – One-time fee per driver

    FMCSA Clearinghouse Query Program $10 Per driver annually

    Payment is due prior to program activation. Non-payment may result in immediate removal from the random testing pool and a non-compliance designation.

    *Setup fee may be required

     

  • Section 7:

    On the DOT Screening Policies
    1.  The information provided must be accurate and complete on the application.  If false data is knowingly submitted, the applicant will be removed from the consortium.
    2. The employer must implement a Substance Abuse Policy and instruct their employees according to the procedures listed in the policy.
    3. The employer understands that they are ultimately responsible for the validation, implementation, and the consequences of their drug and alcohol testing program. The Employer further agrees that they understand the method and policies of On the DOT Screenings.
    4. The Department of Transportation’s program only enrolls drivers that operate under their federal regulations.
      Non-DOT employers may only enroll employees that have been determined to be legally eligible for the DOT’s program.  
    5. Your company must remain current regarding any amounts owed to On The DOT Screenings.  A finance charge of 2% per month will be assessed for amounts greater than 30 days. Employers will be notified in writing within a timely manner.  Failure to pay the indicated amount will result in termination of the account.
    6. Insufficient funds or returned checks will be subject to a $35 returned check and handling fee.  
    7. All notifications for random testing must be responded to within the allotted timeframe.  If a response is not received after a reasonable number of attempts (2), the test will be reported as “Failure to Test” per the DOT regulations. 
    8. Any DOT driver that tests positive on any test provided by On The DOT Screenings will be removed from the consortium pool until the driver is evaluated by a substance abuse professional per the DOT guidelines.  If the driver requests additional testing, it is the responsibility of the employer to pay for any additional cost that will incur including processing of positive testing results.  
    9. Any company found to violate the policies of On The DOT Screenings, the Department of Transportation regulations (49 CFR Part 40) or any additional regulations that govern the consortium, will be terminated and released from the consortium without refund.

     

     

    SECTION 8: TERMINATION AND NON-COMPLIANCE

    This Agreement may be terminated:

    By either party with written notice 30 days prior to termination
    Immediately, by the Consortium, for failure to comply with federal testing requirements
    Upon non-payment of program fees, Consortium will notify Member of any non-compliance and provide documentation for audit defense, where applicable.
     

     

     

  • Section 9:

    Acknowledgment & Signature
  • I, the undersigned, understand that participation in the DOT FMCSA Drug & Alcohol Testing Program is mandatory for safety-sensitive employees and agree to adhere to all responsibilities outlined in this document and under 49 CFR Parts 40 and 382.

     

  • Powered by Jotform SignClear
  •  - -
  • SECTION 10: HOLD HARMLESS AND INDEMNIFICATION AGREEMENT


    This Hold Harmless and Indemnification Agreement (“Agreement”) is made and entered into by and between On The Dot Screenings, a DOT-compliant Drug & Alcohol Testing Consortium operating in the State of Alabama (“Consortium”), and the undersigned Member (“Member”), whether an individual owner-operator or fleet.

    1. Purpose
    The purpose of this Agreement is to establish the responsibilities and liabilities of each party and to ensure that the Consortium is protected against certain liabilities that may arise out of its role in providing DOT-compliant testing and related services.

    2. Hold Harmless
    To the fullest extent permitted by law, the Member agrees to defend, indemnify, and hold harmless On The Dot Screenings, its owners, officers, directors, employees, affiliates, and agents from and against any and all claims, demands, suits, liabilities, losses, damages, fines, penalties, costs, and expenses (including attorney’s fees) arising out of or resulting from:
      - The Member’s failure to comply with DOT regulations (including 49 CFR Part 40 and       Part 382),
    - The Member’s failure to act upon Consortium instructions or notifications,
    - The Member’s own business operations or decisions, including those related to employment or termination of safety-sensitive employees,
    - Misuse or misinterpretation of drug or alcohol test results,
    - Any false or misleading information provided to the Consortium by the Member.

    3. No Assumption of Employer Role
    The Member acknowledges and agrees that On The Dot Screenings acts strictly as a Third Party Administrator (TPA) and Consortium and does not assume the role or responsibilities of the Member's Designated Employer Representative (DER) or employer. The Member retains all duties under FMCSA and DOT regulations for compliance, employee supervision, and reporting.

    4. Limitation of Liability
    The Consortium shall not be liable for any indirect, incidental, consequential, or special damages, including but not limited to lost profits or business interruption, arising out of or related to services provided under this Agreement.

    5. Binding Effect
    This Agreement shall be binding upon and inure to the benefit of the parties and their respective heirs, successors, and assigns.


    IN WITNESS WHEREOF, the parties have executed this Hold Harmless and Indemnification Agreement as of the date indicated below.

  • Powered by Jotform SignClear
  •  - -
  • Should be Empty: